Navigation Links
Allison shares inaugural Tang Prize for his cancer immunotherapy innovation
Date:6/20/2014

The first Tang Prize for Biopharmaceutical Science has been awarded to Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center and Tasuku Honjo, M.D., Ph.D., of Japan's Kyoto University for their research leading to cancer immunotherapy.

"Both scholars' discoveries have opened a new therapeutic era in medicine," said Lee Yuan-tseh, Ph.D., Taiwan's winner of the 1986 Nobel Prize in chemistry, at the award announcement in Taipei, Taiwan, this week.

Taiwanese entrepreneur Samuel Yin established the biennial Tang Prize in December 2012. The 2014 prizes provide a cash award of NT$40 million ($1.3 million) and research grant of NT$10 million.

Allison launched an entirely new way to treat cancer by blocking molecules on immune system T cells that turn off immune response. The treatment, called immune checkpoint blockade, grew out of his basic science research to understand the biology of T cells the immune system's customized attackers.

"Receiving the Tang Prize is a great honor for me, as well as recognition of the growing importance of cancer immunotherapy," Allison said.

Allison developed an antibody to block CTLA-4, an off-switch on T cells, to unleash immune attack on tumors. Ipilimumab, a drug based on his antibody, has extinguished untreatable late-stage melanoma in 22 percent of patients in clinical trials for three years or longer, unprecedented results. The U.S. Food and Drug Administration approved the drug, now called Yervoy, for metastatic melanoma in 2011. Honjo discovered the second immune checkpoint on T cells, called PD1. A variety of experimental drugs to block PD1 and its activating ligand, PD-L1, are showing great promise in clinical trials.

Allison and Honjo were selected from hundreds of international nominees for the award, which recognizes original research that has led to significant advances in preventing, diagnosing and treating major human diseases. Academia Sinica, Taiwan's preeminent academic organization, similar to the National Academy of Sciences in the United States, administered award selection.

Immune checkpoint blockade therapy is spreading to other types of cancers through clinical trials. Researchers are studying how these drugs work in combination with targeted therapies, chemotherapy and each other as well as why they only work for some patients.

Allison is executive director of MD Anderson's immunotherapy platform, which addresses these questions and supports immunotherapy research across multiple cancer types, including the Moon Shots Program, established in 2012 to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

Allison also is deputy director of the David H Koch Center for Applied Research of Genitourinary Cancers and holds the Vivian L. Smith Distinguished Chair in Immunology at MD Anderson.


'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Related medicine news :

1. Cancer immunotherapy leader Allison to receive 2014 Szent-Gyorgyi Prize
2. MD Anderson researcher Jim Allison wins Breakthrough Prize for his innovative cancer immunology rese
3. Allison Kennedy Zeitlin & Company Realtors Hosts Gentle Carousel Mini Therapy Horses
4. The Economist honors cancer immunotherapy pioneer James Allison
5. T cell biology pioneer Allison wins first AACR honor for cancer immunology
6. Forbes Living TV Host Forbes Riley Shares Top Rated House Wares
7. Victory Over Violence: New Book, "Traveling with the Life-Giver" Shares How to Heal After Domestic Abuse
8. New Book "Donald's Story" Shares How to Caregive While Managing Business and Home Life
9. New Book "This Life's Tempestuous Sea" Shares How Fixing Social Problems Can Improve Health
10. Mold Shuts Down 8 Loughman Oaks Elementary School Classrooms, My Cleaning Products Shares Mold Removal Tip How Others Could Prevent Same Problem
11. “Tips To Become A Patient Person,” a New Article on Vkool.Com, Shares Tips with People on How to Be More Patient - V-kool
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Allison shares inaugural Tang Prize for his cancer immunotherapy innovation
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... handheld devices. Through an educational webinar, they will present the line of epMotion ... to learn how easy you can automate everyday pipetting tasks. , Ideal for ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
(Date:8/18/2017)... ... 2017 , ... The Golseth Agency, a Texas based insurance management and financial ... regional charity campaign organized to provide support to Christina Upchurch and her two children ... and her children returned from out of town to find her husband passed away ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... HIGH POINT, N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., ... epilepsy is rumored to be in the beginning stages of an IPO. ... billion annually on epilepsy medications with the average cost of a prescription ... ... Another staggering figure is ...
(Date:8/11/2017)... Israel , Aug. 11, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... on Monday, August 14 and host a conference call ... quarter 2017 operating and financial results and its strategy ... will be hosted by Erez Raphael , Chief ...
(Date:8/7/2017)... , Aug. 7, 2017 Insightin ... member acquisition, retention, and engagement, announced the selection ... Strategy and Product Development, effective as of February 2017. ... and technology implementation strategy for our clients. Wood ... experience in consulting and business analytics within the ...
Breaking Medicine Technology: